{"name":"Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd","slug":"beijing-zhifei-lvzhu-biopharmaceutical-co-ltd","ticker":"","exchange":"","domain":"beijingzhifeilvzhubiopharmaceutical.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Meningococcal ACYW135 Polysaccharide Conjugate Vaccine","genericName":"Meningococcal ACYW135 Polysaccharide Conjugate Vaccine","slug":"meningococcal-acyw135-polysaccharide-conjugate-vaccine","indication":"Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135","status":"phase_3"},{"name":"15-Valent Pneumococcal Conjugate Vaccine","genericName":"15-Valent Pneumococcal Conjugate Vaccine","slug":"15-valent-pneumococcal-conjugate-vaccine","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Meningococcal ACYW135 Polysaccharide Conjugate Vaccine","genericName":"Meningococcal ACYW135 Polysaccharide Conjugate Vaccine","slug":"meningococcal-acyw135-polysaccharide-conjugate-vaccine","phase":"phase_3","mechanism":"This vaccine stimulates the immune system to produce antibodies against meningococcal serogroups A, C, Y, and W-135 by presenting conjugated polysaccharide antigens.","indications":["Prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135"],"catalyst":""},{"name":"15-Valent Pneumococcal Conjugate Vaccine","genericName":"15-Valent Pneumococcal Conjugate Vaccine","slug":"15-valent-pneumococcal-conjugate-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxObzFYejRxZDVHaGNSTDNXMXF0R19DZ0pyWjh1OHFheWdIYWRoNXdUQ1pBNjBkYlh5cEJwWmhSaHljb0g5VzBJUjlsNWZseWIzUDZZd29wYU10dWNCZThqdmtWa3JOR0NOQWR1dW5mT3hKZGM1NDktMjFkVWdYVi1JeENrNVotaUJ0bER5Rkt4Zw?oc=5","date":"2024-11-06","type":"trial","source":"Yahoo Finance","summary":"Tetanus Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight - Yahoo Finance","headline":"Tetanus Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxQM0Jtc1k0b1hXQ2FOZXpWOE12U3AwTFdWcGFuSURhU0lxUlZLLWRHT2UyS2dfckVoZjdha2F0S2Zsc0hqa3VTRFNDb2RwOTdfWjZqbU5RcC1Lb1NxZEdVUEVvb3dnSENidWIxbWxTS0pmVm9lQlREN3MzOWNNX1NPRVNsc3FnblNWc1U5emRncmVMU2RsenJIdkdFamRKTVYtemx6UjdkUlhKUTBwM1VvVVRnT041LXdHNWdETGxQZmtDbi1WZ2RKVENrNC1DVFllYkUzWmw4cWpHWVRuMXNmT0wtWm9ucTJCTTlCY3FtVkxTOEtuRm9XYVNqV3ZvUjdmdXlXN1ZHQ2VPM3RBdGZzcGVWZ1NSRkY1bURUVDBDcGMzZEdaQkMtbA?oc=5","date":"2022-05-02","type":"deal","source":"PR Newswire","summary":"Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical to commercialize Avacc 3 - an OMV based whooping cough vaccine - PR Newswire","headline":"Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical to commercialize Avacc 3 - an OMV bas","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}